Background: The comorbidity of intracranial occlusive arteriopathy and Graves' disease (GD) is increasingly being reported. Methods: We
Moyamoya is a rare idiopathic cerebral vasculopathy characterized by stenosis of the terminal portion of the internal carotid arteries (ICAs) and the development of a thin collateral network of small vessels ("puff of smoke"), initially described as a primary disease in young individuals of Asian descent. 1 Graves' disease (GD) is an autoimmune hyperthyroid state in which antibodies stimulating the thyroid simulating hormone (TSH) receptor, thyroid peroxidase, and thyroglobulin exist, causing hyperthyroidism. A vasculopathy similar to Moyamoya has been identified in association with GD, predominately in Asian population (<70 cases so far). "Moyamoya-like vasculopathy" is a proposed term for this "secondary" vasculopathy. 2 Here we describe first familial presentation of two patients of Latino descent, mother and daughter, with GD and intracranial occlusive arteriopathy.
Diagnosis of Graves' Disease
Traditionally GD has been characterized by hyperthyroidism, diffuse goiter, ophthalmopathy, and dermatopathy. Hyperthyroidism is usually presented with clinical features of weight loss, anxiety, and tremors along with lab testing showing low TSH and high free tri-iodothyronine (T3) and tetra-iodothyronine (T4) levels. Additional testing with antibodies to thyroglobulin, thyroid peroxidase, and TSH receptor help in making the diagnosis; however, their presence is not mandatory for diagnosing GD. 3, 4 Both of our patients presented with undetectable/low TSH and elevated T4 at the time of stroke. Antibodies to thyroid peroxidase, TSH receptor, and thyroglobulin were positive in both of our patients. Patient 1 was diagnosed at a very early age (mentioned below), where as in Patient 2, the diagnosis was made later on when she presented to hospital during the acute episode.
Patient 1 Initial Presentation
A 19-year-old Hispanic woman presented to the hospital in June 2008 with left-sided weakness, which had worsened over 1 week. At age of 16, she was found to have hyperthyroidism, ophthalmopathy, low TSH, high T3 along with positive thyroglobulin, and TSH receptor and thyroid peroxidase antibodies, hence diagnosis of GD was made. She was intermittently taking propylthyouralcil (PTU) and propranolol. There was no history of cardiac diseases, diabetes, dyslipidemia, or smoking. On 
Clinical Course and Prognosis
Two days later, she became lethargic, with left hemiplegia and neglect. Second brain MRI showed progression of the right MCA ischemic stroke, now involving the complete territory of the artery (see Figure 1B) . Occlusion of the right ICA and severe stenosis of the left supraclinoid ICA were seen in follow-up MRA (see Figure 1C ). She rapidly developed malignant brain edema and uncal herniation. Emergent decompressive hemicraniectomy was lifesaving, but she remained in a persistent vegetative state. 
Patient 2 Initial Presentation

Radiologic Findings
Brain MRI showed small acute ischemic infarcts at the left fronto-parietal convexity. Brain MRA revealed stenosis of the terminal portions of both ICAs and proximal segments of both MCAs. Carotid ultrasound showed no significant stenosis bilateral. A cerebral angiogram revealed severe stenosis of the distal cavernous and supraclinoid left ICA and proximal segments of left MCA (see Figure 2A) . On the right, there was moderate stenosis of the M1 segment of MCA (see Figure 3A) . 
Discussion
The association of GD and intracranial occlusive arteriopathy, complicated with ischemic strokes, is increasingly being reported in the scientific literature. [5] [6] [7] The pathogenesis has not been elucidated yet, but the association does not seem to be coincidental. The genetic association in GD is more well established than the genetic association in Moyamoya disease;
it can be argued that familial component may be GD, which causes T-cell dysregulation along with enhancement of sympathetic nerve stimulation at the level of the carotid arteries, leading to vascular injury resulting in Moyamoya syndrome. 8, 9 On the other hand, the majority of patients diagnosed with Moyamoya Another important point worth considering in subjects with emboliclooking strokes and history of hyperthyroidism is that in these patients, work up for cardiac source of embolic stroke (through prolonged Holter monitor or event monitor) should be performed, given high concurrence of cardiac arrhythmias, especially atrial fibrillation with hyperthyroidism. 12 After thorough investigation and ruling out common causes of embolic strokes, diagnosis of Moyamoya should be considered.
We described two patients with GD who developed progressive intracranial arterial stenosis and ischemic strokes. Both patients were thyrotoxic at the moment of the ischemic events. In both patients, other common causes of embolic strokes were ruled out. On the first reported case, the course of the disease was rapidly progressive, leading to ICA occlusion and large hemispheric stroke over only a few days. On the second case, there was evidence of progression of the intracranial stenosis, also leading to occlusion of one ICA over 1 year, when she was thyrotoxic. The disease process stabilized once the hyperthyroidism was well controlled and follow-up studies after 1 year did not show further progression of the stenosis. Hence one can hypothesize management of hyperthyroidism could to be an important factor for the progression of the disease. To the best of our knowledge, this is the first report of familial presentation of the association of GD with intracranial occlusive arteriopathy and ischemic strokes in patients of Latino descent. n
